COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:CRI • FR0000130692
10.24 EUR
-0.06 (-0.58%)
Last: Feb 2, 2026, 07:00 PM
Overall CRI gets a fundamental rating of 3 out of 10. We evaluated CRI against 16 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. While showing a medium growth rate, CRI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- CRI had positive earnings in the past year.
- CRI had a positive operating cash flow in the past year.
- CRI had positive earnings in 4 of the past 5 years.
- In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
- CRI has a Return On Assets of 0.28%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- CRI has a worse Return On Equity (1.03%) than 68.75% of its industry peers.
- CRI has a better Return On Invested Capital (5.14%) than 62.50% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CRI is in line with the industry average of 6.41%.
- The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
- CRI has a Profit Margin of 0.37%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- CRI's Profit Margin has declined in the last couple of years.
- CRI has a Operating Margin (6.41%) which is in line with its industry peers.
- CRI's Operating Margin has been stable in the last couple of years.
- CRI has a worse Gross Margin (28.51%) than 81.25% of its industry peers.
- CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
- Compared to 1 year ago, CRI has more shares outstanding
- Compared to 5 years ago, CRI has more shares outstanding
- The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of CRI (1.24) is worse than 68.75% of its industry peers.
- The Debt to FCF ratio of CRI is 124.09, which is on the high side as it means it would take CRI, 124.09 years of fcf income to pay off all of its debts.
- CRI has a worse Debt to FCF ratio (124.09) than 68.75% of its industry peers.
- CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
- CRI has a Debt to Equity ratio of 1.38. This is in the lower half of the industry: CRI underperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.78
WACC6.58%
2.3 Liquidity
- CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
- CRI has a worse Current ratio (1.30) than 87.50% of its industry peers.
- CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of CRI (0.86) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 150.24% over the past year.
- Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
- Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
- Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
- Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.19% on average per year.
- CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.45% yearly.
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 78.77 indicates a quite expensive valuation of CRI.
- CRI's Price/Earnings ratio is a bit more expensive when compared to the industry. CRI is more expensive than 68.75% of the companies in the same industry.
- When comparing the Price/Earnings ratio of CRI to the average of the S&P500 Index (28.41), we can say CRI is valued expensively.
- CRI is valuated correctly with a Price/Forward Earnings ratio of 13.43.
- CRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRI is cheaper than 75.00% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.64. CRI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.77 | ||
| Fwd PE | 13.43 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than 75.00% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.96 | ||
| EV/EBITDA | 7.37 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CRI's earnings are expected to grow with 32.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.4%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
- CRI has a Yearly Dividend Yield of 1.27%.
- CRI's Dividend Yield is slightly below the industry average, which is at 3.06.
- Compared to the average S&P500 Dividend Yield of 1.83, CRI is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CRI pays out 118.52% of its income as dividend. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 78.77 and the Price/Book (PB) ratio is 0.98.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.